KIF18A inhibitors (Apeiron Therapeutics/University of Vermont)

N/A

Report date: 2025/06/11 11:23:55
NME

Base Information

Drug NameKIF18A inhibitors (Apeiron Therapeutics/University of Vermont)
Drug Alias NameAPRN-AAPRN-B
ClassificationSmall molecules
Mechanisms of ActionKinesin-like protein KIF18A inhibitors
TargetsKinesin-like protein KIF18A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Vermont
China Registration ClassN/A

Develop Information

Active CompaniesGT Apeiron TherapeuticsUniversity Of Vermont
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A